1976 In September, Jiangxi Qingfeng Pharmaceutical Factory, the predecessor of Qingfeng Group, was established.
200 1-2004 reorganization and integration stage:
In May of 20001year, Jiangxi Qingfeng Pharmaceutical Factory was moved from quannan county, Jiangxi to Shahe Industrial Park, Ganzhou, Jiangxi, and renamed as Jiangxi Qingfeng Pharmaceutical Co., Ltd.;
In June of 20001year, it merged with Jiangxi Shanxiang Pharmaceutical Co., Ltd. to realize asset reorganization;
200165438+February, Jiangxi shanxiang pharmaceutical co., ltd passed GMP certification;
In May 2002, the company established a long-term strategic partnership with Jiangxi Institute of Traditional Chinese Medicine.
On June 5438- 10, 2003, Jiangxi Qingfeng Pharmaceutical Co., Ltd. passed GMP certification;
From June 5438 to February 2004, Jiangxi Qingfeng Pharmaceutical Investment Co., Ltd. was formally incorporated.
Development stage of collectivization from 2005 to present:
In 2005 1 month, Pharmaceutical Research Center was established;
In August 2005, the prescription drug marketing management center was established in Shenzhen;
From June, 2006 to February, 2006, the Group launched OTC brand strategy, and comprehensively promoted brand creation.
From June 5438 to February 2006, andrographolide sulfonate and its derivatives were authorized by the national invention patent;
In September, 2007, Anyuan County established a medicinal plant base of Shanxiangyuan.
In February 2008, Jiangxi Qingfeng Pharmaceutical Trade and Investment Co., Ltd. was changed to Jiangxi Qingfeng Pharmaceutical Investment Group Co., Ltd.;
In August 2009, the Group participated in Jiangxi Gannan Haixin Pharmaceutical Co., Ltd.;
In September 2009, Jiangxi Qingfeng Pharmaceutical Trading Co., Ltd. successfully passed GSP certification;
On May 20 10, the standardization laboratory was completed;
On June 20 10, Qingfeng Beijing Company and Qingfeng Hangzhou Institute of Medicine were established.